Metformina Pharma Combix (Metformin Hydrochloride)

Metformin primarily acts by activating AMP‑activated protein kinase (AMPK) in the liver, which suppresses gluconeogenesis—the production of glucose from non‑carbohydrate sources. It also enhances insulin‑mediated glucose uptake in skeletal muscle and adipose tissue, leading to lower circulating glucose concentrations and improved insulin sensitivity.

The exact dose of Metformina Pharma Combix is determined by the prescribing clinician based on individual patient factors such as renal function, glycemic targets, and tolerability. Physicians typically start with a low dose and titrate upward as needed, following local prescribing guidelines and monitoring blood glucose response.

Safety of metformin during pregnancy and lactation varies by region. In some jurisdictions it may be used when the potential benefit outweighs risks, but definitive safety data are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and alternatives with their healthcare provider.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Metformin belongs to the biguanide class and is generally preferred as first‑line therapy because it does not cause weight gain and has a low risk of hypoglycemia compared with sulfonylureas or insulin. Unlike thiazolidinediones, it does not increase fluid retention, and its cardiovascular safety profile is well‑established in large clinical trials.

Metformina Pharma Combix should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most critical risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Other serious concerns include severe hypoglycemia when combined with insulin or sulfonylureas, and long‑term vitamin B12 deficiency.

Metformina Pharma Combix is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with significant hepatic disease. Caution is also advised for individuals with congestive heart failure.